We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Portable Sample-to-Answer PCR System Enables Multiplex Real-Time Detection of 27 Targets

By LabMedica International staff writers
Posted on 13 Sep 2022
Print article
Image: The Franklin mobile thermocycler enables multiplex real-time detection of up to 27 targets (Photo courtesy of Biomeme)
Image: The Franklin mobile thermocycler enables multiplex real-time detection of up to 27 targets (Photo courtesy of Biomeme)

A hand-held, battery-operated mobile thermocycler that weighs just over two pounds and is designed for performing PCR, RT-PCR, qPCR, and isothermal tests on the go enables multiplex real-time detection of up to 27 targets.

Franklin is the latest field-ready mobile thermocycler from Biomeme Inc. (Philadelphia, PA, USA) that can help determine the presence or absence of the target(s) in the sample and even quantify the starting quantity in less than an hour. Compact, lightweight and battery-operated for maximum portability, Franklin is optimized to enable a full day's work out in the field on a single charge of the internal battery. The thermocycler allows users to run experiments offline using the internal battery that powers up to six runs depending on the protocol, then sync via on-board Wi-Fi/cellular. The mobile qPCR thermocycler performs to the standard used by the most advanced labs, but requires no lab equipment or special experience to use. Franklin has been designed by scientists and built for performance, but enables users without PCR-expertise to easily run PCR in the field.

Franklin comes in three different versions, giving users the freedom to start small with a one-color, 9-well mobile qPCR thermocycler and the ability to conveniently add up to two additional color channels through its free companion mobile app, Biomeme Go. The app wirelessly pairs with Franklin so that users can program custom thermocycling parameters, manage their experiments, and more. Its integrated barcode scanner helps prevent human errors by letting the team quickly scan their tests to load pre-determined protocols. Users can simultaneously test up to nine samples or 27 targets using Green (FAM/SYBR), Amber (TexasRedX), and/or Red (ATTO647N) channels. Featuring a point-of-need design, Franklin has been developed for applications that are time and location-sensitive, where results from the field need to be actionable ASAP.

Related Links:
Biomeme Inc.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
New
Nutating Mixer
Enduro MiniMix

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.